SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · Real-Time Price · USD
4.200
+0.010 (0.24%)
At close: Oct 21, 2025, 4:00 PM EDT
4.200
0.00 (0.00%)
After-hours: Oct 21, 2025, 5:17 PM EDT
SOPHiA GENETICS Employees
SOPHiA GENETICS had 423 employees as of December 31, 2024. The number of employees decreased by 7 or -1.63% compared to the previous year.
Employees
423
Change (1Y)
-7
Growth (1Y)
-1.63%
Revenue / Employee
$164,747
Profits / Employee
-$173,511
Market Cap
283.83M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 423 | -7 | -1.63% |
Dec 31, 2023 | 430 | -36 | -7.73% |
Dec 31, 2022 | 466 | -52 | -10.04% |
Dec 31, 2021 | 518 | 103 | 24.82% |
Dec 31, 2020 | 415 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
SOPH News
- 13 hours ago - SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025 - PRNewsWire
- 5 days ago - A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan - PRNewsWire
- 5 days ago - SOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in Oncology - PRNewsWire
- 4 weeks ago - Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy - PRNewsWire
- 4 weeks ago - Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy - GlobeNewsWire
- 4 weeks ago - SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer - PRNewsWire
- 6 weeks ago - SOPHiA GENETICS and Jessa Ziekenhuis Announce Precision Oncology Partnership from the European Congress of Pathology - PRNewsWire
- 2 months ago - SOPHiA GENETICS SA (SOPH) Q2 2025 Earnings Call Transcript - Seeking Alpha